Erratum to: Int J Clin Oncol DOI 10.1007/s10147-016-1039-0
In the original publication of the article, Table 4 was published incorrectly. The corrected Table 4 is published with this erratum.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s10147-016-1039-0.
About this article
Cite this article
Yamamoto, N., Goto, K., Nishio, M. et al. Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer. Int J Clin Oncol 22, 79 (2017). https://doi.org/10.1007/s10147-016-1052-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-016-1052-3